Table 21.
Analysis of multiple drug resistance rate of CREs in 2019.
| Drugs | Drug resistance rate (%) | |
|---|---|---|
| CREs | Ampicillin-sulbactam | 97.1 |
| Imipenem | 88.9 | |
| Ceftriaxone | 84.9 | |
| Ertapenem | 83.6 | |
| Ceftazidime | 82.7 | |
| Nitrofurantoin | 79.4 | |
| Ciprofloxacin | 78.9 | |
| Aztreonam | 77.3 | |
| Levofloxacin | 76.8 | |
| Cefepime | 75.8 | |
| Piperacillin-tazobactam | 74.5 | |
| Cefoperazone-sulbactam | 70.4 | |
| Gentamicin | 53.5 | |
| Tobramycin | 50.0 | |
| Cotrimoxazole | 43.3 | |
| Amikacin | 31.6 | |
| Tigecycline | 0.0 |